CN1857660A - Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer - Google Patents
Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer Download PDFInfo
- Publication number
- CN1857660A CN1857660A CN 200610020566 CN200610020566A CN1857660A CN 1857660 A CN1857660 A CN 1857660A CN 200610020566 CN200610020566 CN 200610020566 CN 200610020566 A CN200610020566 A CN 200610020566A CN 1857660 A CN1857660 A CN 1857660A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- fructus
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer is prepared with ginseng, pinellia tuber, fritillary bulb, bitter orange, ophiopogon root and other 19 kinds of Chinese medicinal materials in certain weight proportion. It has the functions of strengthening resistance to eliminate evil, restoring Qi and blood, balancing Yin-Yang, nourishing Yin to reduce pathogenic fire, etc so as to remit cancer symptoms, inhibit cancer cell growth and eliminate cancer. It has high curative effect and less toxic side effect.
Description
Technical field
The present invention relates to the pharmaceutical composition of a treatment pulmonary carcinoma, esophageal carcinoma, laryngocarcinoma, specifically, relating to a kind of is the Chinese medicine composition of raw material treatment pulmonary carcinoma, esophageal carcinoma, laryngocarcinoma with Chinese medicine.
Background technology
At present, treat method for cancer in the world and mainly contain three kinds, the one, adopt surgical excision, removal lesion tissue prevents the cancerous cell diffusion; The 2nd, adopt chemotherapy or radiation, with kill cancer cell; The 3rd, heal with medicine.The method of employing excision has increased patient's misery, hinders its vigour, and expense is huge.With the method for chemotherapy or radiotherapy, in kill cancer cell, also injure red leukocyte, patient suffers untold misery.The drug main of treatment cancer will comprise chemical synthetic drug and biological preparation at present, and the defective of these medicines is that toxic and side effects is big, and it is narrow to answer medication to enclose, and curative effect is not remarkable, easily recurrence.Toxic and side effects with the Drug therapy cancer that contains Chinese medicinal ingredients is little, but its treatment cycle is long, treats not thorough.At present, can only be used as auxiliary treatment.
Summary of the invention
Therefore, people press for a kind of with in medicinal raw material, therapeutic domain is wide, short treating period, therapeutic effect is good, the Chinese medicine composition of thorough treatment.Up to now, also do not find the report of any relevant Chinese medicine composition of the present invention.Inventor's process years of researches and clinical trial, thus the present invention finished.
It is little to the purpose of this invention is to provide a kind of toxic and side effects, short treating period, thorough treatment, therapeutic effect is good, need not have an operation just can cure pulmonary carcinoma, esophageal carcinoma, laryngocarcinoma Chinese medicine composition.
Another object of the present invention provides the preparation method of this Chinese medicine composition.
Choice of drug Radix Ginseng of the present invention is because it can help vigour; The fire of lung liver can YIN nourishing falls clearly in Radix Adenophorae (Radix Glehniae), Radix Scrophulariae, Radix Ophiopogonis, and the sensible part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels can be gone into Liver and kidney, and the god of whole body vim and vigour body fluid is able to quick recovery; Fructus Schisandrae Chinensis can be received for a long time diffusing vigour of consumption; The Radix Polygoni Multiflori YIN nourishing increases liquid, and its power is grander, and kidney gets its tonification, and lung qi is able to tonification, and negative and positive are in harmonious proportion; It is pure and impure clearly demarcated that drink is washed in method tall building, Arisaema Cum Bile, Poria expectorant, and the bottom of heart QI rising in reverse order is fallen clearly, adds the Caulis Bambusae In Taenia better effects if.Bulbus Fritillariae Cirrhosae can press down cough with dyspnea and the relieving accumulation of pathogens plug; Fructus Aurantii Immaturus, Pericarpium Citri Reticulatae, Semen Armeniacae Amarum, fragrant paying can transfer whole body knot to fill in, and obstructed vapour lock hinders, Fructus Amomi, KOUREN strengthening the spleen and stomach and promoting the circulation of QI; The Radix Paeoniae Alba can be held back liver He Ying, be defended; The Radix Rehmanniae, Radix Salviae Miltiorrhizae can removing heat from blood and promoting blood circulation and enrich blood; Herba Portulacae Grandiflorae, the Herba Hedyotidis Diffusae removing heat from blood that can detoxify is killed cancerous cell; Radix Glycyrrhizae can be separated hundred poison.The synergism of these medicines makes the generation obvious effect.
The consumption of drug component of the present invention is also groped to sum up to draw through the inventor in a large number.Each amounts of components all has effect preferably in the following weight parts scope.
Radix Ginseng 20-30 part Bulbus Fritillariae Cirrhosae 10-15 part Rhizoma Pinelliae Preparata 10-20 part Arisaema Cum Bile 10-20 part
Fructus Aurantii Immaturus 10-15 part 20-30 Radix Ophiopogonis part Fructus Schisandrae Chinensis 10-15 part Radix Adenophorae (Radix Glehniae) 15-20 part
Radix Scrophulariae 15-20 part Poria 10-20 part Semen Armeniacae Amarum 15-20 part Radix Paeoniae Alba 15-30 part
Pericarpium Citri Reticulatae 15-20 part Radix Rehmanniae 15-25 part Radix Polygoni Multiflori 15-20 part Fructus Amomi 15-20 part
The fragrant pair 20-25 part Radix Salviae Miltiorrhizae 25-30 part Fructus Crataegi 15-20 part of KOUREN 15-20 part
Radix Glycyrrhizae 10-15 part Herba Portulacae Grandiflorae 15-20 part Herba Hedyotidis Diffusae 15-20 part Caulis Bambusae In Taenia 15-30 part
Be preferably:
15 parts of 10 parts of Arisaema Cum Bile of 15 parts of Rhizoma Pinelliae Preparata of 30 parts of Bulbus Fritillariae Cirrhosae of Radix Ginseng
18 parts of 12 parts of Radix Adenophorae (Radix Glehniae) of Fructus Aurantii Immaturus 25 parts of Fructus Schisandrae Chinensis, 12 parts of Radix Ophiopogonis
20 parts of 18 portions of Radix Paeoniae Albas of 18 parts of Semen Armeniacae Amarums of 18 parts of Poria of Radix Scrophulariae
18 parts of 18 parts of Fructus Amomis of 20 parts of Radix Polygoni Multiflori of 18 parts of Radix Rehmanniae of Pericarpium Citri Reticulatae
18 parts of perfume (or spice) of KOUREN are paid 18 parts of 28 portions of Fructus Crataegis of 22 parts of Radix Salviae Miltiorrhizaes
21 parts of 18 parts of Caulis Bambusae In Taenia of 18 parts of Herba Hedyotidis Diffusaes of 12 portions of Herba Portulacae Grandifloraes of Radix Glycyrrhizae
The preparation method of medicine of the present invention is as follows:
1) cleans: the above-mentioned Chinese medicine of respectively distinguishing the flavor of is washed respectively;
2) oven dry: respectively each flavor Chinese medicine is dried with dehydrator;
3) pulverize: each flavor Chinese medicine powder is broken into fine powder with pulverizer;
4) mix: take by weighing the Chinese medicine fine powder of respectively distinguishing the flavor of according to the above ratio, it is stirred;
5) preparation type:
Powder: Chinese medicine composition fine powder;
Tablet: in the Chinese medicine composition fine powder, add compressed with adhesive and form;
Pill: make by agitation procedure.
The present invention has the circulation of qi promoting of setting upright, and replies immediately QI and blood, body fluid soon, vigour, reverse personal the bottom of heart function and drive in the wrong direction, make equilibrium between yin and yang, nourishing YIN to lower pathogenic fire, anticancer, drive the effect of persistent ailment, can alleviate the symptom of pulmonary carcinoma that human body is suffered from, esophageal carcinoma and laryngocarcinoma, the anticancer growth, impel the cancer piece to be contracted to disappearance, prolong the effect of patient's life.Can cure in several days initial stage pulmonary carcinoma, esophageal carcinoma, laryngocarcinoma; Pulmonary tuberculosis, consumptive lung disease are contracted and cureless laryngopharyngeal diseases has significant curative effect, to mid-term the cancer first quarter moon cure to January, can advance the medicine person to the late cancer phase, the effect of treatment is also arranged.The defective that the present invention has overcome surgical resection and taken other drug, toxic and side effects is little, short treating period, therapeutic effect is good.
The present invention is that I am own on the basis of inheriting secret prescription handed down in the family from generation to generation, makes through constantly summing up, and in the nearly 40 years career of practising medicine, has successfully cured many cancer patients, and wherein more typical case has:
1, Lv Zhirong, the man, 70 years old, live No. 408 cement plant dormitories of Dujiangyan City, Sichuan Province Kui light path, suffer from chronic laryngocarcinoma, pain unbearably, dysphagia repeatedly arrives province, city's large hospital therapeutic effect is undesirable.Took this Chinese medicine composition one month, health returns to one's perfect health.
2, Sun Shi, the woman 80 years old, lives traffic street, Anju District Baima town, first Suining City, Sichuan.She suffered from stomach carcinoma of gastric cardia and esophageal carcinoma in 2003, and throat blocks, dysphagia, and gas up gushes, and tells food and spits, and takes Chinese medicine composition of the present invention and cures after January.
The specific embodiment
Come further to set forth the present invention by the following examples:
Embodiment 1
1, with crude drug Radix Ginseng, Rhizoma Pinelliae Preparata, Bulbus Fritillariae Cirrhosae, Arisaema Cum Bile, Fructus Aurantii Immaturus, Radix Ophiopogonis, Fructus Schisandrae Chinensis, Radix Adenophorae (Radix Glehniae), Radix Scrophulariae, Poria, Semen Armeniacae Amarum, the Radix Paeoniae Alba, Pericarpium Citri Reticulatae, the Radix Rehmanniae, Radix Polygoni Multiflori, Fructus Amomi, KOUREN, fragrantly pay, Radix Salviae Miltiorrhizae, Fructus Crataegi, Radix Glycyrrhizae, Herba Portulacae Grandiflorae, Herba Hedyotidis Diffusae, Caulis Bambusae In Taenia respectively water clean up.
2, respectively the above-mentioned Chinese medicine of respectively distinguishing the flavor of is dried with dehydrator, make water content less than 5%.
3, with pulverizer above-mentioned kinds of traditional Chinese medicines pulverize separately is become fine powder, make its diameter less than 1mm.
4, take by weighing Radix Ginseng 30 gram, Bulbus Fritillariae Cirrhosae 15 grams, Rhizoma Pinelliae Preparata 10 grams, Arisaema Cum Bile 15 grams, Fructus Aurantii Immaturus 12 grams, Radix Ophiopogonis 25 gram, Fructus Schisandrae Chinensis 12 grams, Radix Adenophorae (Radix Glehniae) 18 grams, Radix Scrophulariae 18 grams, Poria 18 grams, Semen Armeniacae Amarum 18 grams, the Radix Paeoniae Alba 20 grams, Pericarpium Citri Reticulatae 18 grams, the Radix Rehmanniae 20 grams, Radix Polygoni Multiflori 18 grams, Fructus Amomi 18 grams, KOUREN 18 grams, fragrantly pay 22 parts, Radix Salviae Miltiorrhizae 28 grams, Fructus Crataegi 18 grams, Radix Glycyrrhizae 12 grams, Herba Portulacae Grandiflorae 18 grams, Herba Hedyotidis Diffusae 18 grams, Caulis Bambusae In Taenia 22 grams, stir, obtain this Chinese medicine composition 440 gram.This medicine is one pair, can obey 2-3 days, and the child is cut down according to the circumstance.The initial stage cancer patient obeys 2-3 and pays, and can fully recover, and the cancer patient obeyed 6-8 and paid and can fully recover mid-term, and patient with advanced cancer need be taken 10-20 and be paid medicine.
Powder can be used warm boiled water, and Chinese medicine composition of the present invention also can boil crude drug and form by its weight proportion water, directly take.This powder also can be made pill or add compressed with adhesive and become tablets by agitation procedure.
Claims (3)
1, a kind of Chinese medicine composition for the treatment of pulmonary carcinoma, esophageal carcinoma, laryngocarcinoma is characterized in that: it leads it mainly is to be made by following bulk drugs:
Radix Ginseng 20-30 part Bulbus Fritillariae Cirrhosae 10-15 part Rhizoma Pinelliae Preparata 10-20 part Arisaema Cum Bile 10-20 part
Fructus Aurantii Immaturus 10-15 part 20-30 Radix Ophiopogonis part Fructus Schisandrae Chinensis 10-15 part Radix Adenophorae (Radix Glehniae) 15-20 part
Radix Scrophulariae 15-20 part Poria 10-20 part Semen Armeniacae Amarum 15-20 part Radix Paeoniae Alba 15-30 part
Pericarpium Citri Reticulatae 15-20 part Radix Rehmanniae 15-25 part Radix Polygoni Multiflori 15-20 part Fructus Amomi 15-20 part
The fragrant pair 20-25 part Radix Salviae Miltiorrhizae 25-30 part Fructus Crataegi 15-20 part of KOUREN 15-20 part
Radix Glycyrrhizae 10-15 part Herba Portulacae Grandiflorae 15-20 part Herba Hedyotidis Diffusae 15-20 part Caulis Bambusae In Taenia 15-30 part
2, the Chinese drug-treated group according to claim 1 contains thing, and wherein the consumption of each crude drug is:
15 parts of 10 parts of Arisaema Cum Bile of 15 parts of Rhizoma Pinelliae Preparata of 30 parts of Bulbus Fritillariae Cirrhosae of Radix Ginseng
18 parts of 12 parts of Radix Adenophorae (Radix Glehniae) of Fructus Aurantii Immaturus 25 parts of Fructus Schisandrae Chinensis, 12 parts of Radix Ophiopogonis
20 parts of 18 portions of Radix Paeoniae Albas of 18 parts of Semen Armeniacae Amarums of 18 parts of Poria of Radix Scrophulariae
18 parts of 18 parts of Fructus Amomis of 20 parts of Radix Polygoni Multiflori of 18 parts of Radix Rehmanniae of Pericarpium Citri Reticulatae
18 parts of perfume (or spice) of KOUREN are paid 18 parts of 28 portions of Fructus Crataegis of 22 parts of Radix Salviae Miltiorrhizaes
21 parts of 18 parts of Caulis Bambusae In Taenia of 18 parts of Herba Hedyotidis Diffusaes of 12 portions of Herba Portulacae Grandifloraes of Radix Glycyrrhizae
3, according to the preparation method of the Chinese medicine composition of claim 1 or 2, it may further comprise the steps:
1) cleans: the above-mentioned Chinese medicine of respectively distinguishing the flavor of is washed respectively;
2) oven dry: respectively each flavor Chinese medicine is dried with dehydrator;
3) pulverize: each flavor Chinese medicine powder is broken into fine powder with pulverizer;
4) mix: take by weighing the Chinese medicine fine powder of respectively distinguishing the flavor of according to the above ratio, it is stirred;
5) preparation type:
Powder: Chinese medicine composition fine powder;
Tablet: in the Chinese medicine composition fine powder, add compressed with adhesive and form;
Pill: make by agitation procedure.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610020566 CN1857660A (en) | 2006-03-25 | 2006-03-25 | Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 200610020566 CN1857660A (en) | 2006-03-25 | 2006-03-25 | Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1857660A true CN1857660A (en) | 2006-11-08 |
Family
ID=37296648
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 200610020566 Pending CN1857660A (en) | 2006-03-25 | 2006-03-25 | Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1857660A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249235B (en) * | 2008-03-29 | 2010-11-03 | 李玉林 | Chinese medicine for curing esophagus cancer and method of preparing the same |
| CN101991770B (en) * | 2009-08-25 | 2012-07-04 | 吴璨忠 | Medicament for treating malignant tumors |
| CN106729328A (en) * | 2017-02-17 | 2017-05-31 | 王政和 | A kind of Chinese medicine composition for the treatment of cancer and its application |
-
2006
- 2006-03-25 CN CN 200610020566 patent/CN1857660A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101249235B (en) * | 2008-03-29 | 2010-11-03 | 李玉林 | Chinese medicine for curing esophagus cancer and method of preparing the same |
| CN101991770B (en) * | 2009-08-25 | 2012-07-04 | 吴璨忠 | Medicament for treating malignant tumors |
| CN106729328A (en) * | 2017-02-17 | 2017-05-31 | 王政和 | A kind of Chinese medicine composition for the treatment of cancer and its application |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1317026C (en) | Traditional Chinese medicine prepn. for treating lithiasis and its prepn. method | |
| CN101066445A (en) | Chinese medicine prepn for curing gastropathy radically | |
| CN1354014A (en) | Gongbu ointment | |
| CN104173937A (en) | Traditional Chinese medicine composition for dispersing stagnated liver qi for promoting bile flow and applications thereof | |
| CN101590168B (en) | Traditional Chinese medicine combination for treating gout and preparation method thereof | |
| CN1857660A (en) | Chinese medicine composition for treating lung cancer, esophagus carcinoma and throat cancer | |
| CN103656499A (en) | Traditional Chinese medicinal mixture for treating gallbladder polyps, and preparation method thereof | |
| CN103705578B (en) | There is blood fat reducing and Chinese medicine preparation suppressing blood glucose rising effect and preparation method thereof | |
| CN102657795A (en) | Traditional Chinese medicine preparation for promoting postoperative incision healing | |
| CN1762454A (en) | Chinese traditional medicinal composition for treating psoriasis | |
| CN102145143B (en) | Pharmaceutical composition for treatment of gastritis and preparation method of pharmaceutical composition | |
| CN101375965B (en) | Chinese medicine honeyed bolus for treating recurrent psoriasis in progressive stage | |
| CN1827160A (en) | Chinese medicinal composition for treating enteritis | |
| CN1168482C (en) | Chinese medicine composition for treating enteritis | |
| CN1277571C (en) | Chinese medicine preparation for stomach diseases | |
| CN102091181A (en) | Chinese medicinal composition for treating acute and chronic granulocytic leukemia 1 and preparation method thereof | |
| CN102085274A (en) | Traditional Chinese medicine composition for treating acute, chronic and subacute leukemia and preparation method thereof | |
| CN101028421A (en) | Chinese medicine for treating chronic kidney failure | |
| CN1121236C (en) | Medicine for curing rheumatoid arthritis and preparing method | |
| CN1072940C (en) | Oral liquid for anti-cancer | |
| CN100496594C (en) | Gastropathy treating Chinese medicine composition | |
| CN106421534A (en) | Traditional Chinese medicinal composition for treating rheumatoid arthritis and preparation method thereof | |
| CN1217688C (en) | Medicine for treating chronic gastritis and preparing process thereof | |
| CN100413518C (en) | Capsule for treating cirrhosis ascites and its preparation technology | |
| CN1194719C (en) | Medicine prescription for curing nephropathy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Open date: 20061108 |
|
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20061108 |